Sgs Formulation Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.35 Cr
- Revenue Growth 60.13%
- Profit Growth 25.62%
- Ebitda 28.72%
- Net Worth 19.10%
- Total Assets 1.75%
About Sgs Formulation
Sgs Formulation Private Limited (SFPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 December 2016 (Eight years and two months 14 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹2.35 Cr.
Saravanan Sagadevan, Premkumari, and Gnanadhas Kumar serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999TN2016PTC113571
-
Company No.
113571
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Dec 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Sgs Formulation?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saravanan Sagadevan
|
Director | 01-Dec-2016 | Current |
|
Premkumari
|
Director | 01-Dec-2016 | Current |
|
Gnanadhas Kumar
|
Director | 01-Dec-2016 | Current |
Financial Performance of Sgs Formulation.
Sgs Formulation Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.13% increase. The company also saw a substantial improvement in profitability, with a 25.62% increase in profit. The company's net worth Soared by an impressive increase of 19.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sgs Formulation?
Unlock access to Sgs Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Puduvaibazaar Private LimitedPremkumari is a mutual person
Charges (Loans)
₹23.51 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 1.19 Cr
- Others : 0.81 Cr
- The South Indian Bank Limited : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 2023 | The South Indian Bank Limited | ₹3.50 M | Open |
| 29 Dec 2021 | Others | ₹8.10 M | Open |
| 09 Mar 2018 | Indian Bank | ₹1.19 Cr | Open |
How Many Employees Work at Sgs Formulation?
Sgs Formulation has a workforce of 11 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sgs Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sgs Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.